CRISPR Therapeutics AG Collaboration Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to Amended and Restated Joint Development and Commercialization Agreement between Vertex Pharmaceuticals and CRISPR Therapeutics
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2023
Amendment No. 1 to Strategic Collaboration and License Agreement between Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2021
Amendment No. 2 to Research Collaboration Agreement between ViaCyte, Inc. and CRISPR Therapeutics AG
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2020
Strategic Collaboration and License Agreement between Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2019
Amendment No. 2 to Strategic Collaboration, Option and License Agreement between Vertex Pharmaceuticals and CRISPR Therapeutics
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2019
Amendment No. 1 to Strategic Collaboration, Option and License Agreement between Vertex Pharmaceuticals and CRISPR Therapeutics
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2017
Joint Development and Commercialization Agreement between Vertex Pharmaceuticals and CRISPR Therapeutics
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
DE
2017
Amendment No. 1 to Research Collaboration Agreement between ViaCyte, Inc. and CRISPR Therapeutics AG
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2020